Tenet Healthcare Corporation Aktie News

Buying a stock is easy, but buying the right stock without a good strategy is incredibly hard. Here are five top-performing stocks to buy now or put on a watchlist.

Tenet Healthcare (THC) remains a compelling 'buy' due to strong growth, margin expansion, and deep undervaluation versus peers. THC's Ambulatory Care segment drives profitability, with nearly half of projected EBITDA from just 24% of revenue. Management has aggressively reduced leverage and repurchased $1.19B in stock, signaling balance sheet strength and shareholder alignment.

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in aggregate principal amount of senior secured first lien notes due on November 15, 2032, which will bear interest at a rate of 5.500% per annum (the “first lien notes”), and $0.75 billion in aggregate...

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced private placement offerings of $1.5 billion in aggregate principal amount of new senior secured first lien notes due 2032 (the “first lien notes”) and $0.5 billion in aggregate principal amount of new senior notes due 2033 (the “senior notes” and together with the first lien notes, the “notes”) to refinance $2.0 b...

Tenet Healthcare Corporation (NYSE:THC ) Q3 2025 Earnings Call October 28, 2025 10:30 AM EDT Company Participants William McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman & CEO Sun Park - Executive VP & CFO Conference Call Participants Kevin Fischbeck - BofA Securities, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Craig Hettenbach - Morga...

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended September 30, 2025. "Our high acuity service line focus and operational discipline enabled us to deliver strong same store revenue growth and attractive operational performance and free cash flow in the third quarter," said Saum Sutaria, M.D., Chairman and Chief Executive ...

Tenet Healthcare is rated BUY, driven by its strategic shift to high-margin outpatient care and strong growth in its USPI division. THC benefits from policy tailwinds, expanding outpatient-eligible procedures, and attractive valuation with a forward EV/EBITDA of 7.33, well below industry peers. Key risks include heavy reliance on Medicare/Medicaid, ongoing litigation at St. Vincent Hospital, an...

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2025 results before the market opens on Tuesday, October 28, 2025, to be followed by a conference call at 9:30 a.m. CT (10:30 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. A...